PCSK6 and clinical outcomes in the Pulmonary Fibrosis Foundation Patient Registry
Abstract Background Higher plasma proprotein convertase subtilisin/kexin type 6 (PCSK6) concentration has been associated with increased all-cause mortality in idiopathic pulmonary fibrosis (IPF). Its role across the broader spectrum of fibrotic interstitial lung disease (ILDs) remains unclear. We e...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2026-04-01
|
| Edice: | Respiratory Research |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s12931-026-03642-1 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
